Algoet M, Janssens S, Himmelreich U, Gsell W, Pusovnik M, Van den Eynde J, Oosterlinck W (2023) Myocardial ischemia-reperfusion injury and the influence of inflammation. Trends Cardiovasc Med 33:357–366. https://doi.org/10.1016/j.tcm.2022.02.005

Article  CAS  PubMed  Google Scholar 

Amput P, Palee S, Arunsak B, Pratchayasakul W, Thonusin C, Kerdphoo S, Jaiwongkam T, Chattipakorn SC, Chattipakorn N (2020) PCSK9 inhibitor and atorvastatin reduce cardiac impairment in ovariectomized prediabetic rats via improved mitochondrial function and Ca(2+) regulation. J Cell Mol Med 24:9189–9203. https://doi.org/10.1111/jcmm.15556

Article  CAS  PubMed  PubMed Central  Google Scholar 

Andreadou I, Tsoumani M, Vilahur G, Ikonomidis I, Badimon L, Varga ZV, Ferdinandy P, Schulz R (2020) PCSK9 in myocardial infarction and cardioprotection: importance of lipid metabolism and inflammation. Front Physiol 11:602497. https://doi.org/10.3389/fphys.2020.602497

Article  PubMed  PubMed Central  Google Scholar 

Aschner M, Skalny AV, Lu R, Martins AC, Tizabi Y, Nekhoroshev SV, Santamaria A, Sinitskiy AI, Tinkov AA (2024) Mitochondrial pathways of copper neurotoxicity: focus on mitochondrial dynamics and mitophagy. Front Mol Neurosci 17:1504802. https://doi.org/10.3389/fnmol.2024.1504802

Article  PubMed  PubMed Central  Google Scholar 

Brandes RP, Weissmann N, Schröder K (2010) NADPH oxidases in cardiovascular disease. Free Radic Biol Med 49:687–706. https://doi.org/10.1016/j.freeradbiomed.2010.04.030

Article  CAS  PubMed  Google Scholar 

Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, Claeys MJ, Dan GA, Dweck MR, Galbraith M, Gilard M, Hinterbuchner L, Jankowska EA, Jüni P, Kimura T, Kunadian V, Leosdottir M, Lorusso R, Pedretti RFE, Rigopoulos AG, Rubini Gimenez M, Thiele H, Vranckx P, Wassmann S, Wenger NK, Ibanez B (2023) ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 44:3720–3826. https://doi.org/10.1093/eurheartj/ehad191

Article  CAS  PubMed  Google Scholar 

Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Ž, Riccardi G, Taskinen MR, Tokgozoglu L, Verschuren WMM, Vlachopoulos C, Wood DA, Zamorano JL, Cooney MT (2016) ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J 37:2999–3058. https://doi.org/10.1093/eurheartj/ehw272

Article  PubMed  Google Scholar 

Chen N, Guo L, Wang L, Dai S, Zhu X, Wang E (2024) Sleep fragmentation exacerbates myocardial ischemia-reperfusion injury by promoting copper overload in cardiomyocytes. Nat Commun 15:3834. https://doi.org/10.1038/s41467-024-48227-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

D’Onofrio N, Prattichizzo F, Marfella R, Sardu C, Martino E, Scisciola L, Marfella L, Grotta R, Frigé C, Paolisso G, Ceriello A, Balestrieri ML (2023) SIRT3 mediates the effects of PCSK9 inhibitors on inflammation, autophagy, and oxidative stress in endothelial cells. Theranostics 13:531–542. https://doi.org/10.7150/thno.80289

Article  CAS  PubMed  PubMed Central  Google Scholar 

Del Re DP, Amgalan D, Linkermann A, Liu Q, Kitsis RN (2019) Fundamental mechanisms of regulated cell death and implications for heart disease. Physiol Rev 99:1765–1817. https://doi.org/10.1152/physrev.00022.2018

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ding Z, Liu S, Wang X, Mathur P, Dai Y, Theus S, Deng X, Fan Y, Mehta JL (2016) Cross-talk between PCSK9 and damaged mtDNA in vascular smooth muscle cells: role in apoptosis. Antioxid Redox Signal 25:997–1008. https://doi.org/10.1089/ars.2016.6631

Article  CAS  PubMed  Google Scholar 

Ding Z, Pothineni NVK, Goel A, Lüscher TF, Mehta JL (2020) PCSK9 and inflammation: role of shear stress, pro-inflammatory cytokines, and LOX-1. Cardiovasc Res 116:908–915. https://doi.org/10.1093/cvr/cvz313

Article  CAS  PubMed  Google Scholar 

Ding Z, Wang X, Liu S, Shahanawaz J, Theus S, Fan Y, Deng X, Zhou S, Mehta JL (2018) PCSK9 expression in the ischaemic heart and its relationship to infarct size, cardiac function, and development of autophagy. Cardiovasc Res 114:1738–1751. https://doi.org/10.1093/cvr/cvy128

Article  CAS  PubMed  Google Scholar 

Fang X, Ji Y, Li S, Wang L, He B, Li B, Liang B, Yin H, Chen H, Dingda D, Wu B, Gao F (2024) Paeoniflorin attenuates cuproptosis and ameliorates left ventricular remodeling after AMI in hypobaric hypoxia environments. J Nat Med 78:664–676. https://doi.org/10.1007/s11418-024-01781-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han X, Gao Y, He M, Luo Y, Wei Y, Duan Y, Zhang S, Yu H, Kan J, Hou T, Zhang Y, Li Y (2024) Evolocumab prevents atrial fibrillation in rheumatoid arthritis rats through restraint of PCSK9 induced atrial remodeling. J Adv Res 61:211–221. https://doi.org/10.1016/j.jare.2023.09.007

Article  CAS  PubMed  Google Scholar 

Heusch G (2020) Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol 17:773–789. https://doi.org/10.1038/s41569-020-0403-y

Article  PubMed  Google Scholar 

Heusch G (2024) Myocardial ischemia/reperfusion: translational pathophysiology of ischemic heart disease. Med 5:10–31. https://doi.org/10.1016/j.medj.2023.12.007

Article  CAS  PubMed  Google Scholar 

Huo S, Wang Q, Shi W, Peng L, Jiang Y, Zhu M, Guo J, Peng D, Wang M, Men L, Huang B, Lv J, Lin L (2023) ATF3/SPI1/SLC31A1 signaling promotes cuproptosis induced by advanced glycosylation end products in diabetic myocardial injury. Int J Mol Sci. https://doi.org/10.3390/ijms24021667

Article  PubMed  PubMed Central  Google Scholar 

Kamiya T, Kwon AH, Kanemaki T, Matsui Y, Uetsuji S, Okumura T, Kamiyama Y (1998) A simplified model of hypoxic injury in primary cultured rat hepatocytes. In Vitro Cell Dev Biol Anim 34:131–137. https://doi.org/10.1007/s11626-998-0095-9

Article  CAS  PubMed  Google Scholar 

Kasichayanula S, Grover A, Emery MG, Gibbs MA, Somaratne R, Wasserman SM, Gibbs JP (2018) Clinical pharmacokinetics and pharmacodynamics of evolocumab, a PCSK9 inhibitor. Clin Pharmacokinet 57:769–779. https://doi.org/10.1007/s40262-017-0620-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lambert G, Sjouke B, Choque B, Kastelein JJ, Hovingh GK (2012) The PCSK9 decade. J Lipid Res 53:2515–2524. https://doi.org/10.1194/jlr.R026658

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leander K, Mälarstig A, Van’t Hooft FM, Hyde C, Hellénius ML, Troutt JS, Konrad RJ, Öhrvik J, Hamsten A, de Faire U (2016) Circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) predicts future risk of cardiovascular events independently of established risk factors. Circulation 133:1230–1239. https://doi.org/10.1161/circulationaha.115.018531

Article  CAS  PubMed  Google Scholar 

Liao Y, Wang D, Gu C, Wang X, Zhu S, Zheng Z, Zhang F, Yan J, Gu Z (2024) A cuproptosis nanocapsule for cancer radiotherapy. Nat Nanotechnol. https://doi.org/10.1038/s41565-024-01784-1

Article  PubMed  Google Scholar 

Lin QY, Zhang YL, Bai J, Liu JQ, Li HH (2021) VEGF-C/VEGFR-3 axis protects against pressure-overload induced cardiac dysfunction through regulation of lymphangiogenesis. Clin Transl Med 11:e374. https://doi.org/10.1002/ctm2.374

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martín P, Sánchez-Madrid F (2025) T cells in cardiac health and disease. J Clin Invest. https://doi.org/10.1172/JCI185218

Article  PubMed  PubMed Central  Google Scholar 

Martino E, D’Onofrio N, Balestrieri A, Mele L, Sardu C, Marfella R, Campanile G, Balestrieri ML (2023) MiR-15b-5p and PCSK9 inhibition reduces lipopolysaccharide-induced endothelial dysfunction by targeting SIRT4. Cell Mol Biol Lett 28:66. https://doi.org/10.1186/s11658-023-00482-5

Article  CAS